Talimogene Laherparepvec and Panitumumab for the Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Skin

NCT04163952 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Locally Advanced Skin Squamous Cell Carcinoma
Metastatic Skin Squamous Cell Carcinoma
Recurrent Skin Squamous Cell Carcinoma

Interventions

BIOLOGICAL: Panitumumab
BIOLOGICAL: Talimogene Laherparepvec

Sponsor

Rutgers, The State University of New Jersey

Collaborators

[object Object]